IL-4-induced peroxisome proliferator-activated receptor γ activation inhibits NF-κB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: Implication for CNS-demyelinating diseases

Journal of Immunology

Volumn 176, Issue 7, 2006, Pages 4385-4398

  Paintlia, Ajaib S ^a   Paintlia, Manjeet K ^a   Singh, Inderjit ^a   Singh, Avtar K ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NUCLEAR FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; RECEPTOR ANTIBODY; SMALL INTERFERING RNA; SYNAPTOPHYSIN; AUTACOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; GLIA CELL; IMMUNOBLOTTING; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; TH1 CELL; TRANSACTIVATION; ANIMAL; DRUG EFFECT; GENETICS; GLIA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PROTEIN TRANSPORT; SECRETION; SIGNAL TRANSDUCTION; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; DEMYELINATING DISEASES; INFLAMMATION MEDIATORS; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LIPOXYGENASE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; NEUROGLIA; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OLIGODENDROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; STEM CELLS; TRANS-ACTIVATION (GENETICS);

EID: 33646050051     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.7.4385     Document Type: Article

References (61)

1. Noseworthy, J. H., C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker. 2000. Multiple sclerosis. N. Engl. J. Med. 343: 938-952.
2. Lindert, R.-B., C. G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld. 1999. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122(Pt. 11): 2089-2100.
3. Sun, J. B., T. Olsson, W. Z. Wang, B. G. Xiao, V. Kostulas, S. Fredrikson, H. P. Ekre, and H. Link. 1991. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21: 1461-1468.
4. Kerlero de Rosbo, N., M. Hoffman, I. Mendel, I. Yust, J. Kaye, R. Bakimer, S. Flechter, O. Abramsky, R. Milo, A. Karni, and A. Ben-Nun. 1997. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur. J. Immunol. 27: 3059-3069.
5. Genain, C. P., B. Cannella, S. L. Hauser, and C. S. Raine. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5: 170-175.
6. Raine, C. S., B. Cannella, S. L. Hauser, and C. P. Genain. 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46: 144-160.
7. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am. J. Pathol. 130: 443-454.
8. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139: 4016-4021.
9. Prineas, J. W., and J. S. Graham. 1981. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 10: 149-158.
10. Storch, M. K., S. Piddlesden, M. Haltia, M. Iivanainen, P. Morgan, and H. Lassmann. 1998. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43: 465-471.
11. Chu, C. Q., S. Wittmer, and D. K. Dalton. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192: 123-128.
12. Selmaj, K., and C. S. Raine. 1988. Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Ann. NY Acad. Sci. 540: 568-570.
13. Akassoglou, K., J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, G. Kollias, and L. Probert. 1998. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153: 801-813.
14. Takahashi, J. L., F. Giuliani, C. Power, Y. Imai, and V. W. Yong. 2003. Interleukin-1β promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol. 53: 588-595.
15. Ferrari, C. C., A. M. Depino, F. Prada, N. Muraro, S. Campbell, O. Podhajcer, V. H. Perry, D. C. Anthony, and F. J. Pitossi. 2004. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am. J. Pathol. 165: 1827-1837.
16. Sherwin, C., and R. Fern. 2005. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-α, IL-1β, and calcium. J. Immunol. 175: 155-161.
17. Mason, J. L., K. Suzuki, D. D. Chaplin, and G. K. Matsushima. 2001. Interleukin-1β promotes repair of the CNS. J. Neurosci. 21: 7046-7052.
18. Vela, J. M., E. Molina-Holgado, A. Arévalo-Martín, G. Almazán, and C. Guaza. 2002. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 20: 489-502.
19. Molina-Holgado, E., J. M. Vela, A. Arévalo-Martín, and C. Guaza. 2001. LPS/IFN-γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 13: 493-502.
20. Renno, T., V. Taupin, L. Bourbonnière, G. Verge, E. Tran, R. De Simone, M. Krakowski, M. Rodriguez, A. Peterson, and T. Owens. 1998. Interferon-γ in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 12: 376-389.
21. Tran, E. H., H. Hardin-Pouzet, G. Verge, and T. Owens. 1997. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74: 121-129.
22. Danilov, A. I., M. Andersson, N. Bavand, N. P. Wiklund, T. Olsson, and L. Brundin. 2003. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J. Neuroimmunol. 136: 112-118.
23. Cua, D. J., D. R. Hinton, and S. A. Stohlman. 1995. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease. J. Immunol. 155: 4052-4059.
24. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 22: 1757-1763.
25. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961-1966.
26. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
27. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, et al. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185: 1711-1714.
28. Liblau, R., L. Steinman, and S. Brocke. 1997. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol. 9: 799-803.
29. Miller, A., S. Shapiro, R. Gershtein, A. Kinarty, H. Rawashdeh, S. Honigman, and N. Lahat. 1998. Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J. Neuroimmunol. 92: 113-121.
30. Molina-Holgado, E., A. Arévalo-Martín, S. Ortiz, J. M. Vela, and C. Guaza. 2002. Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10. Neurosci. Lett. 324: 237-241.
31. Molina-Holgado, E., A. Arévalo-Martín, A. Castrillo, L. Boscá, J. M. Vela, and C. Guaza. 2002. Interleukin-4 and interleukin-10 modulate nuclear factor κB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes. J. Neurochem. 81: 1242-1252.
32. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-κB-p300 pathway independent of peroxisome proliferator-activated receptor γ. J. Immunol. 173: 5196-5208.
33. Paintlia, A. S., M. K. Paintlia, M. Khan, T. Vollmer, A. K. Singh, and I. Singh. 2005. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB J. 19: 1407-1421.
34. Paintlia, A. S., A. G. Gilg, M. Khan, A. K. Singh, E. Barbosa, and I. Singh. 2003. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol. Dis. 14: 425-439.
35. Paintlia, A. S., M. K. Paintlia, A. K. Singh, R. Stanislaus, A. G. Gilg, E. Barbosa, and I. Singh. 2004. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin. J. Neurosci. Res. 77: 63-81.
36. Back, S. A., B. H. Han, N. L. Luo, C. A. Chricton, S. Xanthoudakis, J. Tam, K. L. Arvin, and D. M. Holtzman. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci. 22: 455-463.
37. Buntinx, M., M. Moreels, F. Vandenabeele, I. Lambrichts, J. Raus, P. Steels, P. Stinissen, and M. Ameloot. 2004. Cytokine-induced cell death in human oligodendroglial cell lines. I. Synergistic effects of IFN-γ and TNF-α on apoptosis. J. Neurosci. Res. 76: 834-845.
38. Dukic-Stefanovic, S., J. Gasic-Milenkovic, W. Deuther-Conrad, and G. Münch. 2003. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J. Neurochem. 87: 44-55.
39. Giri, S., N. Nath, B. Smith, B. Viollet, A. K. Singh, and I. Singh. 2004. 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J. Neurosci. 24: 479-487.
40. Emerson, M. R., and S. M. LeVine. 2004. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Brain Res. 1021: 140-145.
41. Wujek, J. R., C. Bjartmar, E. Richer, R. M. Ransohoff, M. Yu, V. K. Tuohy, and B. D. Trapp. 2002. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 61: 23-32.
42. Bjartmar, C., and B. D. Trapp. 2003. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox. Res. 5: 157-164.
43. Lassmann, H., W. Brück, and C. Lucchinetti. 2001. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7: 115-121.
44. Ding, M., M. Zhang, J. L. Wong, N. E. Rogers, L. J. Ignarro, and R. R. Voskuhl. 1998. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160: 2560-2564.
45. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160: 2940-2946.
46. Dalton, D. K., and S. Wittmer. 2005. Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice. J. Neuroimmunol. 160: 110-121.
47. Barnett, M. H., and J. W. Prineas. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55: 458-468.
48. 2 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168: 2508-2515.
49. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400: 378-382.
50. Ricote, M., J. S. Welch, and C. K. Glass. 2000. Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor-γ. Horm. Res. 54: 275-280.
51. Delerive, P., P. Gervois, J. C. Fruchart, and B. Staels. 2000. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J. Biol. Chem. 275: 36703-36707.
52. Ruan, H., H. J. Pownall, and H. F. Lodish. 2003. Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-κB. J. Biol. Chem. 278: 28181-28192.
53. Bennett, B. L., R. Cruz, R. G. Lacson, and A. M. Manning. 1997. Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB. J. Biol. Chem. 272: 10212-10219.
54. Ohmori, Y., and T. A. Hamilton. 2000. Interleukin-4/STAT6 represses STAT1 and NF-κB-dependent transcription through distinct mechanisms. J. Biol. Chem. 275: 38095-38103.
55. Norenberg, M. D. 1994. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol 53: 213-220.
56. Liberto, C. M., P. J. Albrecht, L. M. Herx, V. W. Yong, and S. W. Levison. 2004. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89: 1092-1100.
57. Brodie, C., N. Goldreich, T. Haiman, and G. Kazimirsky. 1998. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J. Neuroimmunol. 81: 20-30.
58. Hooper, D. C., K. Morimoto, M. Bette, E. Weihe, H. Koprowski, and B. Dietzschold. 1998. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 72: 3711-3719.
59. Karulin, A. Y., M. D. Hesse, H. C. Yip, and P. V. Lehmann. 2002. Indirect IL-4 pathway in type 1 immunity. J. Immunol. 168: 545-553.
60. Brenner, T., R. Arnon, M. Sela, O. Abramsky, Z. Meiner, R. Riven-Kreitman, N. Tarcik, and D. Teitelbaum. 2001. Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone. J. Neuroimmunol. 115: 152-160.
61. von Büdingen, H.-C., S. L. Hauser, J.-C. Ouallet, N. Tanuma, T. Menge, and C. P. Genain. 2004. Frontline: epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 34: 2072-2083.